These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus. Meyer A, Kausch I, Krüger S, Fetscher S, Böhle A, Jocham D. Urology; 2004 Feb; 63(2):381-2. PubMed ID: 14972505 [Abstract] [Full Text] [Related]
3. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9]. Kondoh K, Noguchi S, Shuin T, Masuda M, Kubota Y, Hosaka M. Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585 [Abstract] [Full Text] [Related]
4. [A case of pyonephrosis caused by ureteral stones with elevated serum levels of CA19-9]. Aoki D, Nomata K, Kanda S, Sawase K, Kanetake H, Saito Y, Tsuda N. Hinyokika Kiyo; 1999 Sep; 45(9):629-32. PubMed ID: 10540710 [Abstract] [Full Text] [Related]
7. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis. Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC. J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879 [Abstract] [Full Text] [Related]
8. Normal interleukin-10 serum level opposed to high serum levels of carbohydrate antigen 19-9 and cancer antigens 125 and 50 in a case of true splenic cyst. Lieto E, Castellano P, Ferraraccio F, Orditura M, De Vita F, Romano C, Pignatelli C, Galizia G. Arch Med Res; 2003 Jun; 34(2):145-8. PubMed ID: 12700012 [Abstract] [Full Text] [Related]
11. [Primary adenocarcinoma of the renal pelvis with a pyeloduodenal fistula: a case report]. Tsuchiya T, Yoh M, Ito Y, Ban Y. Hinyokika Kiyo; 2001 Jun; 47(6):421-3. PubMed ID: 11496399 [Abstract] [Full Text] [Related]
19. Multiple epithelial cysts of the spleen and on the splenic capsule, and high serum levels of CA19-9, CA125 and soluble IL-2 receptor. Hashimoto T, Sugino T, Fukuda T, Hoshi N, Ogura G, Watanabe K, Satoh Y, Hasegawa T, Ohishi A, Haga J, Miyata M, Suzuki T. Pathol Int; 2004 May; 54(5):349-54. PubMed ID: 15086840 [Abstract] [Full Text] [Related]
20. Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy. Cecchi E, Lapi F, Vannacci A, Banchelli G, Mazzei T, Mugelli A. J Clin Pharm Ther; 2009 Feb; 34(1):129-32. PubMed ID: 19125912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]